Core Insights - Oruka Therapeutics, Inc. is a clinical stage biotechnology company focused on developing novel biologics for chronic skin diseases, particularly plaque psoriasis [2] - The company aims to provide patients with significant freedom from their conditions through high rates of complete disease clearance with infrequent dosing [2] Upcoming Events - Oruka will present at TD Cowen's 45th Annual Health Care Conference on March 4, 2025, at 10:30 AM ET [1] - The company will also present at the Leerink Global Healthcare Conference on March 12, 2025, at 8:40 AM ET [1] - A webcast and replay of the presentations will be available on Oruka's investor events website [1] Company Overview - Oruka is advancing a proprietary portfolio of potentially best-in-class antibodies engineered by Paragon Therapeutics, targeting the core mechanisms of plaque psoriasis and other dermatologic and inflammatory diseases [2] - The company's mission is to achieve high rates of complete disease clearance for patients suffering from chronic skin diseases [2]
Oruka Therapeutics to Present at Multiple March Investor Conferences